PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of springeropenLink to Publisher's site
Archivum Immunologiae et Therapiae Experimentalis
 
From:
Published online 2016 December 8. doi: 10.1007/s00005-016-0430-x

Table 1

Baseline characteristics of 321 patients with CLL at the time of diagnosis

CharacteristicsPatients
N (%)Median (range)
Age (≤60 years/>60 years)119 (37)/202 (63)64 (38–85)
Gender (female/male)144 (45)/177 (55)
Hemoglobin (g/dL)13.3 (4.4–17.3)
Platelet count (109/L)178 (3–745)
Rai stage (0–II/III–IV)266 (83)/55 (17)
β2M (normal/elevated/unknown)48 (24)/156 (76)/1172833 (950–12.790)
LDH (normal/elevated/unknown)136 (65)/72 (35)/113291 (94–1278)
CD38 [low (≤30%)/high (>30%)/unknown]202 (73)/76 (27)/4310.74 (0–100)
ZAP-70 [low (<20%)/high (≥20%)/unknown]141 (75)/48 (25)/1327.59 (0–74.94)
17 deletion (present/absent/unknown)18 (9)/183 (91)/120
IGHV mutation status (yes/no/unknown)a 97 (53)/85 (47)/21
Treatment (yes/no/unknown)180 (58)/133 (42)/8
TFS10 (0–123)
Death (yes/no/unknown)38 (18)/178 (82)/105
OS
 Death pts., time to death in months49.5 (5–143)
 Living pts. time to last examination in months64 (1–259)

aOnly in first cohort (203 pts.)